Verrica Pharmaceuticals Inc. (VRCA)

NCM – Real vaqt narxi. Valyuta: USD

5.12

-0.10 (-1.92%)

Bozor ochiq: Aug 12, 2026, 11:55 AM EDT

5.22

0.00 (0.00%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

07.08.2026

Verrica Pharmaceuticals Q2 Earnings Call Highlights

Verrica Pharmaceuticals NASDAQ: VRCA reported second-quarter revenue growth in its YCANTH treatment for molluscum contagiosum, while outlining progress in pivotal studies of the product for common warts and announcing a credit facility that management said could extend its cash runway into 2028.

07.08.2026

Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call Transcript

07.08.2026

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates

Verrica Pharmaceuticals Inc. (VRCA) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to earnings of $0.02 per share a year ago.

Videolar

No Data

There is no data to display

Verrica Pharmaceuticals Inc. (VRCA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Q2 Earnings Call Highlights

Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call Transcript

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates

Videolar

No Data

Verrica Pharmaceuticals Q2 Earnings Call Highlights

Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call Transcript

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates

Videolar

No Data

Search stocks

Verrica Pharmaceuticals Inc. (VRCA)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Q2 Earnings Call Highlights

Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call Transcript

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates

Videolar

No Data

Verrica Pharmaceuticals Q2 Earnings Call Highlights

Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call Transcript

Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Beats Revenue Estimates

Videolar

No Data